Both in Pharmaceuticals
Insmed vs BridgeBio Pharma
Over the past year INSM returned −40.6% and BBIO returned +19.7%; their daily moves had a correlation of 0.23.
INSM −40.6% BBIO +19.7%Growth of $1, one year, split-adjusted
| Metric | INSM | BBIO |
|---|---|---|
| Price | $112.58 | $74.95 |
| Market cap | $24.70B | $14.60B |
| Today | +0.89% | +5.97% |
| 1 month | +3.7% | +12.0% |
| 6 months | −15.5% | +9.3% |
| Year to date | −35.3% | −2.0% |
| 1 year | −32.6% | +12.5% |
| Revenue growth (YoY) | +268.4% | +192.6% |
| Gross margin | 85.1% | 94.2% |
| Net margin | −19.1% | −23.5% |
| P/E (TTM) | — | — |
| Price / sales | 16.3× | 15.4× |
| Net cash | $569.9M | -$938.6M |
| Dividend yield | — | — |
| Volatility (60d) | 46.7% | 32.7% |
| Short % of float | 6.3% | 12.5% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).